Cingulate Stock Return On Asset
Fundamental analysis of Cingulate allows traders to better anticipate movements in Cingulate's stock price by examining its financial health and performance throughout various phases of its business cycle.
Cingulate | Build AI portfolio with Cingulate Stock |
Cingulate Company Return On Asset Analysis
Cingulate's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Cingulate Return On Asset | -1.07 |
Most of Cingulate's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cingulate is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Cingulate has a Return On Asset of -1.0665. This is 87.81% lower than that of the Biotechnology sector and 95.48% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Cingulate Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cingulate's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cingulate could also be used in its relative valuation, which is a method of valuing Cingulate by comparing valuation metrics of similar companies.Cingulate is currently under evaluation in return on asset category among its peers.
Cingulate Fundamentals
| Return On Equity | -2.76 | ||||
| Return On Asset | -1.07 | ||||
| Current Valuation | 25.15 M | ||||
| Shares Outstanding | 6.76 M | ||||
| Shares Owned By Insiders | 1.50 % | ||||
| Shares Owned By Institutions | 4.37 % | ||||
| Number Of Shares Shorted | 284.87 K | ||||
| Price To Book | 7.68 X | ||||
| Gross Profit | (12.1 M) | ||||
| EBITDA | (14.89 M) | ||||
| Net Income | (15.55 M) | ||||
| Cash And Equivalents | 8.2 M | ||||
| Cash Per Share | 0.73 X | ||||
| Total Debt | 5.1 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 10.94 X | ||||
| Book Value Per Share | 0.58 X | ||||
| Cash Flow From Operations | (18.45 M) | ||||
| Short Ratio | 1.78 X | ||||
| Earnings Per Share | (2.77) X | ||||
| Target Price | 26.48 | ||||
| Number Of Employees | 13 | ||||
| Beta | -0.75 | ||||
| Market Capitalization | 26.69 M | ||||
| Total Asset | 14.86 M | ||||
| Retained Earnings | (108.49 M) | ||||
| Working Capital | 7.69 M | ||||
| Net Asset | 14.86 M |
Currently Active Assets on Macroaxis
| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price | |
| PRFDX | T Rowe Price | |
| RPBAX | T Rowe Price |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Tools for Cingulate Stock
When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |